Physician

John Phillip Miller, M.D.

According to 2025 Medicare claims, John Miller, M.D. (NPI: 1104087469) practices internal medicine in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is TUSKALOOSA INTERNAL MEDICINE LLC (NPI: 1235221847; TIN: 63-0479242) and primary practice location at 35404-2959. Miller is affiliated with the Aledade 79 AL MSSP Enhanced (ACO ID: A4894), participating under the MSSP model.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 612 traditional Medicare patients, billed 14,222 HCPCS/CPT codes, and received $272,379 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 16,537 prescription claims across 1,085 beneficiaries totaling $1,169,480 in drug costs, led by Eliquis (Apixaban). DME data shows 77 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $459,377 to $272,379. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $465,849 to $1,169,480. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $12,971 and ending at $8,461.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,676	19,501	$459,377
2016	1,535	18,078	$473,502
2017	982	15,366	$336,518
2018	939	14,720	$295,022
2019	1,148	29,998	$410,760
2020	1,008	20,167	$340,308
2021	803	15,126	$307,633
2022	756	15,334	$313,005
2023	700	13,774	$271,920
2024	612	14,222	$272,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	844	8,456	$465,849
2016	810	7,544	$381,530
2017	705	8,346	$435,284
2018	935	9,314	$510,256
2019	1,157	14,967	$896,395
2020	1,139	17,862	$1,052,880
2021	1,144	18,699	$1,074,730
2022	1,181	18,167	$1,089,422
2023	1,127	16,990	$1,199,916
2024	1,085	16,537	$1,169,480

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	114	341	$10,931
2016	93	223	$4,416
2017	45	91	$1,024
2018	25	93	$1,120
2019	60	209	$2,701
2020	53	297	$37,861
2021	43	334	$102,913
2022	38	176	$5,895
2023	23	107	$4,137
2024	16	77	$7,058

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	404	667	$85
80061	Blood test, lipids (cholesterol and triglycerides)	431	817	$13
80053	Blood test, comprehensive group of blood chemicals	437	896	$10
36415	Insertion of needle into vein for collection of blood sample	449	1,036	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	395	700	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	206	10,280	$198,012
Ozempic	Semaglutide	156	5,686	$165,533
Januvia	Sitagliptin Phosphate	105	6,810	$126,250
Mounjaro	Tirzepatide	46	1,546	$56,232
Xarelto	Rivaroxaban	40	2,700	$48,559

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	25	$6,411
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	38	$630
A4259	Lancets, per box of 100	N	N/R	14	$17

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for John Phillip Miller, M.D.?

Tedicare shows public-source Medicare data for John Phillip Miller, M.D. (NPI 1104087469), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Phillip Miller, M.D. have ACO affiliation data?

John Phillip Miller, M.D. is shown with ACO affiliation data for Aledade 79 AL MSSP Enhanced (MSSP, ACO ID A4894).

What billing organization is linked to John Phillip Miller, M.D.?

John Phillip Miller, M.D. is linked to TUSKALOOSA INTERNAL MEDICINE LLC (billing NPI 1235221847) in the available physician profile data.

Does John Phillip Miller, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.